
Family Offices Bet Big on Healthcare as April Deal Flow Rebounds
Private-wealth investors increased direct deals in April to 55 (up from 39 in March), with nearly one-third in healthcare and life sciences. Emerson Collective backed Ultralight and Stipple Bio, signaling bets influenced by personal experiences; Dolby Family Ventures supported Exciva as well. The shift comes amid a broader appetite for healthcare innovation despite looming NIH funding cuts, highlighted by JPMorgan Private Bank's finding that healthcare is a top investment theme for family offices.
